04Mar
Global Private Equity Newsletter - Winter 2020 Edition: Deals in the Life Sciences Sector Article 1: Value Drivers and Risks
As the private equity industry matures, and the deal landscape becomes more competitive, private equity sponsors are becoming more prepared and capable of investing in sectors previously considered overly-regulated, requiring advanced chemistry or...
By:
Dechert LLP
Related
Can management of a Delaware corporation block members of the board of directors from gaining access...
Read More >
Correcting your late deferrals by depositing them and making a contribution to make up for lost earn...
Read More >
In its February 26, 2020, unanimous decision in Intel Corporation Investment Policy Committee v. Sul...
Read More >
With 169 special purpose acquisition company (SPAC) initial public offerings (IPOs) and 102 SPAC mer...
Read More >
The Illinois legislature recently passed a law modifying the Contractor Prompt Payment Act, impactin...
Read More >
2020 is now behind us, and we have reason for a positive outlook for 2021. However, delays and impac...
Read More >